Global orthopedic sales totaled $59 billion in 2023, an increase of 6.5% compared to 2022. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
Global orthopedic sales totaled $59 billion in 2023, an increase of 6.5% compared to 2022. Read our regularly updated analysis of the orthopedic market, including sales forecasts for all segments, company revenue and insight into key trends.
Stay up to date on the orthopedic market’s 4Q performance in 2023 as we update this post with company sales data and industry developments.
While economic pressure slowed orthopedic funding in recent years, there is ample capital for enabling technology companies.
The company grew in the low double-digits in 2023 but a strategic review revealed Anika’s need to focus on the greatest growth opportunities.
The company grew in the mid-teens in 2023 with significant growth across product segments and most regions.
The company turned in a strong fourth quarter to push 2023 orthopedic sales growth into the low-single-digits.
The company grew in the high teens for 2023, driven by its personalized solutions and strength across geographic regions.
The company grew more than 20% in 2023 as it consistently wins share in its Trauma and Deformity business.
Funding announcements came from familiar names and supported well-backed markets like spine and enabling technology.
Proceeds will accelerate aprevo personalized lumbar and cervical patient-specific interbody fusion devices.
While Orthofix’s trauma business is growing slower than the market, it has an enormous opportunity in the U.S.
Stay up to date on the orthopedic market’s 4Q performance in 2023 as we update this post with company sales data and industry developments.
The company grew in the low double-digits in 2023 but a strategic review revealed Anika’s need to focus on the greatest growth opportunities.
The company grew in the mid-teens in 2023 with significant growth across product segments and most regions.
The company turned in a strong fourth quarter to push 2023 orthopedic sales growth into the low-single-digits.
The company grew in the high teens for 2023, driven by its personalized solutions and strength across geographic regions.
The company grew more than 20% in 2023 as it consistently wins share in its Trauma and Deformity business.
The company will be funded to complete product development and an initial commercial launch of a functional MTP implant that reduces pain and preserves motion.
As a guest member you get access to more articles and webinars every month.
We’ll send a recovery link to your email.
Return to Homepage